CRXT Annual FCF
-$43.81 M
-$2.17 M-5.21%
31 December 2021
Summary:
As of February 5, 2025, CRXT annual free cash flow is -$43.81 million, with the most recent change of -$2.17 million (-5.21%) on December 31, 2021. During the last 3 years, it has fallen by -$2.17 million (-5.21%).CRXT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRXT Quarterly FCF
-$17.50 M
-$223.00 K-1.29%
30 June 2022
Summary:
As of February 5, 2025, CRXT quarterly free cash flow is -$17.50 million, with the most recent change of -$223.00 thousand (-1.29%) on June 30, 2022. Over the past year, it has dropped by -$2.60 million (-17.44%).CRXT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRXT TTM FCF
-$56.63 M
-$2.60 M-4.81%
30 June 2022
Summary:
As of February 5, 2025, CRXT TTM free cash flow is -$56.63 million, with the most recent change of -$2.60 million (-4.81%) on June 30, 2022. Over the past year, it has dropped by -$34.68 million (-157.96%).CRXT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRXT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.2% | -17.4% | -158.0% |
| 3 y3 years | -5.2% | - | - |
| 5 y5 years | -5.2% | - | - |
CRXT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +5.2% | +148.1% | +703.0% |
Clarus Therapeutics Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$17.50 M(+1.3%) | -$56.63 M(+4.8%) |
| Mar 2022 | - | -$17.28 M(+85.0%) | -$54.04 M(+23.3%) |
| Dec 2021 | -$43.81 M | -$9.34 M(-25.4%) | -$43.81 M(+27.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$12.52 M(-16.0%) | -$34.47 M(+57.0%) |
| June 2021 | - | -$14.90 M(+111.3%) | -$21.95 M(+211.3%) |
| Mar 2021 | - | -$7.05 M | -$7.05 M |
| Dec 2020 | -$41.64 M | - | - |
FAQ
- What is Clarus Therapeutics Holdings annual free cash flow?
- What is the all time high annual FCF for Clarus Therapeutics Holdings?
- What is Clarus Therapeutics Holdings annual FCF year-on-year change?
- What is Clarus Therapeutics Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for Clarus Therapeutics Holdings?
- What is Clarus Therapeutics Holdings quarterly FCF year-on-year change?
- What is Clarus Therapeutics Holdings TTM free cash flow?
- What is the all time high TTM FCF for Clarus Therapeutics Holdings?
- What is Clarus Therapeutics Holdings TTM FCF year-on-year change?
What is Clarus Therapeutics Holdings annual free cash flow?
The current annual FCF of CRXT is -$43.81 M
What is the all time high annual FCF for Clarus Therapeutics Holdings?
Clarus Therapeutics Holdings all-time high annual free cash flow is -$41.64 M
What is Clarus Therapeutics Holdings annual FCF year-on-year change?
Over the past year, CRXT annual free cash flow has changed by -$2.17 M (-5.21%)
What is Clarus Therapeutics Holdings quarterly free cash flow?
The current quarterly FCF of CRXT is -$17.50 M
What is the all time high quarterly FCF for Clarus Therapeutics Holdings?
Clarus Therapeutics Holdings all-time high quarterly free cash flow is -$7.05 M
What is Clarus Therapeutics Holdings quarterly FCF year-on-year change?
Over the past year, CRXT quarterly free cash flow has changed by -$2.60 M (-17.44%)
What is Clarus Therapeutics Holdings TTM free cash flow?
The current TTM FCF of CRXT is -$56.63 M
What is the all time high TTM FCF for Clarus Therapeutics Holdings?
Clarus Therapeutics Holdings all-time high TTM free cash flow is -$7.05 M
What is Clarus Therapeutics Holdings TTM FCF year-on-year change?
Over the past year, CRXT TTM free cash flow has changed by -$34.68 M (-157.96%)